WEITZMAN DEBORAH (CEO, Pharmaceutical Segment) received a stock award from CARDINAL HEALTH INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/6/2026ACC: 0000721371-26-000030
Officer· CEO, Pharmaceutical Segment
Since Sep 2022
+54.82K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
54.82K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+54.82K
Price / share
—
Trade value
—
% of position
103.7%
8/4/2026
52.88K→107.70K
Total
Net shares
+54.82K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/4/2026 | A · Award | +54.82K | — | — | 103.7% | 52.88K | 107.70K |
| Total | +54.82K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported